Ameriprise’s Aehr Test Systems AEHR Stock Holding History

Ameriprise’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.07M	Buy	+31,946	New	+$2.92M	﹤0.01%	2852
2025 Q2	–	Sell	-408,401	Closed	-$2.98M	–	3957
2025 Q1	$2.98M	Sell	408,401 -872,454	-68%	-$9.65M	﹤0.01%	2674
2024 Q4	$21.3M	Sell	1,280,855 -6,521	-0.5%	-$86.9K	0.01%	1290
2024 Q3	$16.5M	Buy	1,287,376 +902,713	+235%	+$13.1M	﹤0.01%	1440
2024 Q2	$4.3M	Sell	384,663 -750,285	-66%	-$8.74M	﹤0.01%	2423
2024 Q1	$14.1M	Buy	1,134,948 +176,641	+18%	+$2.94M	﹤0.01%	1516
2023 Q4	$25.4M	Buy	958,307 +596,892	+165%	+$17.4M	0.01%	1118
2023 Q3	$16.5M	Buy	361,415 +102,144	+39%	+$4.74M	0.01%	1347
2023 Q2	$10.7M	Sell	259,271 -1,114,758	-81%	-$36.6M	﹤0.01%	1720
2023 Q1	$42.6M	Buy	+1,374,029	New	+$44.3M	0.01%	830

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise's AEHR Position: Q2 2026 in Review

Ameriprise opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 31,946 shares worth $3.07M. The stake represents ﹤0.01% of the portfolio and ranks #2852 among its holdings. This is a return to the name: Ameriprise previously reported a position in AEHR as recently as Q1 2025.

Ameriprise first reported a position in AEHR in Q1 2023 and has held it in 10 quarters since. The position peaked at $42.6M in Q1 2023. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Ameriprise held 31,946 shares of Aehr Test Systems worth $3.07M as of Q2 2026.
Aehr Test Systems was a new Ameriprise position in Q2 2026.
Aehr Test Systems made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2852 holding.
Ameriprise first reported a position in Aehr Test Systems in Q1 2023 and has held it in 10 quarters since.
Ameriprise's Aehr Test Systems position peaked at $42.6M in Q1 2023.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.